Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neutralizing Antibody Titers 6 Years After the Third Dose of Inactivated Japanese Encephalitis Vaccine and Projected Duration of Protection

NCT02039440 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT02039440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02039440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neutralizing Antibody Titers 6 Years After the Third Dose of Inactivated Japanese Encephalitis Vaccine and Projected Duration of Protection
Lead sponsor
Medical University of Vienna
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2014
Completion date
June 30, 2014
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post other specified vaccination encephalitis